
The next few years hold great promise, as new agents emerge and others consolidate their place on our shelves. We will be forced to rethink strategies and redefine management as a new era of immuno-oncology dawns.
Your AI-Trained Oncology Knowledge Connection!
Published: March 15th 2015 | Updated: